Pulished Date August, 2019
ID: 118
Share on
Share on

Asia Pacific Preventive Vaccine Market Research Report – Segmented By Vaccine Type, By End User, By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 118
Pages: 145

APAC Preventive Vaccine Market Size & Growth (2019 – 2024)

As per our recently published report, the Preventive Vaccine Market size in the Asia Pacific is valued at $6.15 Billion in 2019 and is estimated to reach $11.79 billion by the end of 2024 with a CAGR of 13.89 %.

A recent increase in the demand is owed to the rising incidences of cancer & HIV cases. World Health Organization growth estimations show a huge potential for the market with the arrival of new therapeutic preventive and adult vaccines.

The vaccine market is quite different from any other product market, having distinct features with the increased complexity of assessing, understanding prices and procurement. Although it is a small market compared to the pharmaceutical market, we cannot dismiss the fact that it is growing at a fast rate. There are currently around 120 new vaccines in the pipeline of various multinational companies across the world and are set to hit the market in the coming years. While the vaccine market is rather concentrated on both supply and demand sides, it is mostly dependent on public purchasers and donor policies.

Invested from governments for vaccine development, increase in funding by the major market players, rising occurrence of disease, technological advancements decreasing the new vaccine development time drastically, initiatives by NGOs are some of the factors that are propelling the growth of vaccines market. However, massive capital requirements and stringent regulatory policies, high costs associated with treatment are few factors crippling the growth of the market.

This research report segmented and sub-segmented the APAC Preventive Vaccine Market into the following categories:

APAC Preventive Vaccine Market -By Vaccine Type:

  • Live, Attenuated Vaccines
  • Inactivated Vaccines             
  • Toxoid Vaccines    
  • Subunit Vaccines  
  • Conjugate Vaccines             
  • DNA Vaccines         
  • Recombinant Vector Vaccines          

APAC Preventive Vaccine Market -By End-User:

  • Pediatric Vaccine
    • Pneumococcal
    • MMR
    • Varicella
    • Hepatitis
    • Poliovirus
    • HIB
    • Others
  • Adult Vaccines      
    • Influenza
    • Cervical Cancer
    • Hepatitis
    • Zoster
    • Others

APAC Preventive Vaccine Market - By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Historically many of the multinational vaccine companies have been investing huge sums in research and development resulting in new innovations in the market.

Most promising companies in the APAC Preventive Vaccine Market profiled in the report are :

  • GlaxoSmithKline, plc.
  • Bavarian Nordic
  • Merck and Company
  • CSL Limited
  • Novartis AG
  • Emergent BioSolutions Inc.
  • Johnson and Johnson
  • MedImmune
  • LLC
  • Pfizer, Inc.
  • Sanofi Pasteur.
  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                            

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                     

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Vaccine Type                                                                       

                                5.1.1 Live, Attenuated Vaccines                                                

                                5.1.2 Inactivted Vaccines                                                             

                                5.1.3 Toxoid Vaccines                                                    

                                5.1.4 Subunit vaccines                                                  

                                5.1.5 Conjugate vaccines                                                             

                                5.1.6 DNA vaccines                                                         

                                5.1.7 Recombinant vector vaccines                                                          

                5.2 By End User                                                               

                                5.2.1 Paediatric Vaccine                                               

                                                5.2.1.1 Pneumococcal                                   

                                                5.2.1.2 MMR                                     

                                                5.2.1.3 Varicella                               

                                                5.2.1.4 Hepatitis                                              

                                                5.2.1.5 Poliovirus                                             

                                                5.2.1.6 HIB                                         

                                                5.2.1.7 Others                                  

                                5.2.2 Adult Vaccines                                                      

                                                5.2.2.1 Influenza                                             

                                                5.2.2.2 Cervical Cancer                                 

                                                5.2.2.3 Hepatitis                                              

                                                5.2.2.4 Zoster                                   

                                                5.2.2.5 Others                                  

  1. Geographical Analysis

                6.1 Introduction                                                                              

                6.2 China                                                                            

                6.3 India                                                                              

                6.4 Japan                                                                            

                6.5 South Korea                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 GlaxoSmithKline, plc.                                                                             

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Merck and Company                                                                              

                8.3 Bavarian Nordic                                                                        

                8.4 CSL Limited                                                                 

                8.5 Emergent BioSolutions Inc.                                                                  

                8.6 Novartis AG                                                                

                8.7 Johnson and Johnson                                                                             

                8.8 MedImmune, LLC                                                                    

                8.9 Pfizer, Inc.                                                                   

                8.10 Sanofi Pasteur                                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Preventive Vaccines Market By Region, From 2019-2024( USD Billion )
  2. Asia-Pacific Preventive Vaccines Market By Vaccine Type, From 2019-2024( USD Billion )
  3. Asia-Pacific Live, Attenuated Vaccines Market By Region, From 2019-2024( USD Billion )
  4. Asia-Pacific Inactivated Vaccines Market By Region, From 2019-2024( USD Billion )
  5. Asia-Pacific Toxoid Vaccines Market By Region, From 2019-2024( USD Billion )
  6. Asia-Pacific Subunit vaccines Market By Region, From 2019-2024( USD Billion )
  7. Asia-Pacific Conjugate vaccines Market By Region, From 2019-2024( USD Billion )
  8. Asia-Pacific DNA vaccines Market By Region, From 2019-2024( USD Billion )
  9. Asia-Pacific Recombinant vector vaccines Market By Region, From 2019-2024( USD Billion )
  10. Asia-Pacific Preventive Vaccines Market By End User, From 2019-2024( USD Billion )
  11. Asia-Pacific Paediatric Vaccines Market By Region, From 2019-2024( USD Billion )
  12. Asia-Pacific Adult Vaccines Market By Region, From 2019-2024( USD Billion )
  13. Asia-Pacific Paediatric Vaccines Market By Type, From 2019-2024( USD Billion )
  14. Asia-Pacific Pneumococcal Vaccines Market By Region, From 2019-2024( USD Billion )
  15. Asia-Pacific MMR Vaccines Market By Region, From 2019-2024( USD Billion )
  16. Asia-Pacific Varicella Vaccines Market By Region, From 2019-2024( USD Billion )
  17. Asia-Pacific Hepatitis Vaccines Market By Region, From 2019-2024( USD Billion )
  18. Asia-Pacific Poliovirus Vaccines Market By Region, From 2019-2024( USD Billion )
  19. Asia-Pacific HIB Vaccines Market By Region, From 2019-2024( USD Billion )
  20. Asia-Pacific Other Paediatric Vaccines Market By Region, From 2019-2024( USD Billion )
  21. Asia-Pacific Adult Vaccines Market By Type, From 2019-2024( USD Billion )
  22. Asia-Pacific Influenza Vaccines Market By Region, From 2019-2024( USD Billion )
  23. Asia-Pacific Cervical Cancer Vaccines Market By Region, From 2019-2024( USD Billion )
  24. Asia-Pacific Hepatitis Vaccines Market By Region, From 2019-2024( USD Billion )
  25. Asia-Pacific Zoster Vaccines Market By Region, From 2019-2024( USD Billion )
  26. Asia-Pacific Other Adult Vaccines Market By Region, From 2019-2024( USD Billion )
  27. China Preventive Vaccines Market By Vaccine Type, From 2019-2024( USD Billion )
  28. China Preventive Vaccines Market By End User, From 2019-2024( USD Billion )
  29. India Preventive Vaccines Market By Vaccine Type, From 2019-2024( USD Billion )
  30. India Preventive Vaccines Market By End User, From 2019-2024( USD Billion )
  31. Japan Preventive Vaccines Market By Vaccine Type, From 2019-2024( USD Billion )
  32. Japan Preventive Vaccines Market By End User, From 2019-2024( USD Billion )
  33. South Korea Preventive Vaccines Market By Vaccine Type, From 2019-2024( USD Billion )
  34. South Korea Preventive Vaccines Market By End User, From 2019-2024( USD Billion )
  35. China Paediatric Vaccines Market By Type, From 2019-2024( USD Billion )
  36. India Paediatric Vaccines Market By Type, From 2019-2024( USD Billion )
  37. Japan Paediatric Vaccines Market By Type, From 2019-2024( USD Billion )
  38. South Korea Paediatric Vaccines Market By Type, From 2019-2024( USD Billion )
  39. China Adult Vaccines Market By Type, From 2019-2024( USD Billion )
  40. India Adult Vaccines Market By Type, From 2019-2024( USD Billion )
  41. Japan Adult Vaccines Market By Type, From 2019-2024( USD Billion )
  42. South Korea Adult Vaccines Market By Type, From 2019-2024( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample